Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Cancer Health Center

Font Size

Chemo Nausea Patch Approved

5-Day Sancuso Patch Fights Nausea From Cancer Chemotherapy
WebMD Health News
Reviewed by Louise Chang, MD

Sept. 15, 2008 -- The FDA has approved Sancuso, a five-day patch that fights nausea from cancer chemotherapy.

Sancuso continuously delivers a steady dose of a drug called granisetron, which blocks serotonin receptors and helps prevent nausea.

Nausea is a common side effect of chemotherapy. Not all chemotherapy patients experience this side effect, but it can be life- threatening. Some patients have to prematurely stop their cancer treatment because of severe nausea and vomiting.

Granisetron, delivered by injection or orally via tablets or solution, is sold under the brand name Kytril by Roche Pharmaceuticals. The Sancuso patch is from Scotland-based ProStrakan International.

"A patch that can be applied before treatment, releasing medication consistently into the bloodstream over a number of days, has the potential to impact patient comfort and quality of life," oncology nurse practitioner Barbara Rogers, CRNP, of Fox Chase Cancer Center, said in a ProStrakan news release.

The transparent Sancuso patch is applied to the upper arm.

The FDA approval was based on results from a Phase III clinical trial in which Sancuso was compared with once-daily oral granisetron and placebo. The patch prevented chemotherapy-induced nausea and vomiting as well as the oral product did, according to the company news release.

The most important Sancuso side effect in the clinical trial was constipation. Overall, nearly 9% of patients experienced adverse reactions related to the drug, but the drug was generally well tolerated.

According to the FDA, Sancuso may be used to prevent nausea and vomiting in patients receiving nausea-inducing chemotherapy regimens for up to five consecutive days.

ProStrakan says Sancuso should be available to patients in December.

Today on WebMD

Colorectal cancer cells
New! I AM Not Cancer Facebook Group
Lung cancer xray
See it in pictures, plus read the facts.
sauteed cherry tomatoes
Fight cancer one plate at a time.
Ovarian cancer illustration
Real Cancer Perspectives
Jennifer Goodman Linn self-portrait
what is your cancer risk
colorectal cancer treatment advances
breast cancer overview slideshow
prostate cancer overview
lung cancer overview slideshow
ovarian cancer overview slideshow
Actor Michael Douglas